Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Racial Disparities in COVID-19: Causes, Consequences, and Clinical Strategies

What accounts for racial disparities in COVID-19 outcomes? Hear expert insights on the healthcare inequities affecting patients who are Black, indigenous, or people of color and learn about strategies for overcoming barriers to optimal COVID-19 care.
person default
Oni Blackstock, MD
person default
Nina T. Harawa, PhD, MPH
David Malebranche, MD, MPH
Stephaun Elite Wallace, PhD, MS
Released: October 28, 2021

Information on this Educational Activity

Faculty

Oni Blackstock, MD

Founder & Executive Director
Health Justice
New York, New York

Oni Blackstock, MD, MHS, has no relevant conflicts of interest to report.
Nina T. Harawa, PhD, MPH

Professor of Medicine and Epidemiology
Department of Medicine and Psychiatry
UCLA David Geffen School of Medicine
Charles R. Drew University of Medicine and Science
Los Angeles, California

Nina T. Harawa, PhD, MPH, has disclosed that she has received funds for research support and fees for non-CME/CE services from Gilead Sciences.
David Malebranche, MD, MPH

Internal Medicine Physician
HIV/Sexual Health Specialist
AIDS Healthcare Foundation (AHF) Medical Clinic
Atlanta, Georgia

David Malebranche, MD, MPH, has disclosed that he has received consulting fees from Gilead Sciences and ViiV Healthcare and funds for non-CME/CE services from Gilead Sciences.
Stephaun Elite Wallace, PhD, MS

Staff Scientist
Director of External Relations

Vaccine and Infectious Disease Division
Fred Hutchinson Cancer Research Center
Clinical Assistant Professor
Global Health
University of Washington
Seattle, Washington

Stephaun E. Wallace, PhD, MS, has disclosed that he has received consulting fees from ViiV Healthcare and funds for research support from Johnson & Johnson/Janssen.

Program Medium

This program has been made available online.

Related Content

Download slides reviewing the latest data and guidance on COVID-19 symptoms and clinical manifestations, from Clinical Care Options (CCO)

Arthur Kim, MD Sharon R. Lewin, AO, FRACP, PhD, FAHMS Renslow Sherer, MD Released: January 6, 2022

Download slides reviewing the latest data and guidance on COVID-19 prevention and treatment in special populations, from Clinical Care Options (CCO)

Arthur Kim, MD Sharon R. Lewin, AO, FRACP, PhD, FAHMS Renslow Sherer, MD Released: January 6, 2022

Prof. Sharon R. Lewin gives expert insight on IV and oral antiviral agents for nonhospitalized patients with COVID-19, from Clinical Care Options (CCO)

Sharon R. Lewin, AO, FRACP, PhD, FAHMS Released: January 6, 2022

Download slides reviewing the latest data and guidance on COVID-19 diagnosis and transmission, from Clinical Care Options (CCO)

Arthur Kim, MD Sharon R. Lewin, AO, FRACP, PhD, FAHMS Renslow Sherer, MD Released: December 29, 2021
Produced in collaboration with
Educational grant provided by:
Gilead Sciences, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings